Sun Pharma has entered into an exclusive licencing agreement with China Medical System Holdings (CMSH) to develop and commercialise seven generic products in Mainland China.
Sun Pharma reports Q1 net profit at Rs 1,387 crore
Sun Pharmaceutical on Tuesday reported a net profit of Rs 1,387 crore in the April to June quarter of 2019-20, up 31 per cent in the year-on period.